Gene · 411
Papers1,563
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,563
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparative Analysis of Arsenic Transport and Tolerance Mechanisms: Evolution from Prokaryote to Higher Plants. | Cells | 2022 | 36078150 | PubTator, text mining | PubMed |
| Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants. | Int J Mol Sci | 2022 | 36077388 | PubTator, text mining | PubMed |
| Testing and Optimizing Guided Thinking Tasks to Promote Physical Activity: Protocol for a Randomized Factorial Trial. | JMIR Res Protoc | 2022 | 36074550 | PubTator, text mining | PubMed |
| Comparison of growth dynamics in different types of MPS: an attempt to explain the causes. | Orphanet J Rare Dis | 2022 | 36064607 | PubTator, text mining | PubMed |
| Co-occurrence of dual carbapenemases KPC-2 and OXA-48 with the mobile colistin resistance gene mcr-9.1 in Enterobacter xiangfangensis. | Front Cell Infect Microbiol | 2022 | 36061873 | PubTator, text mining | PubMed |
| Mucopolysaccharidosis VI in a European Shorthair cat: Neurological presentation, computed tomography findings and genetic investigation. | Acta Vet Hung | 2022 | 36037045 | PubTator, text mining | PubMed |
| Generation of a novel disease model mouse for mucopolysaccharidosis type VI via c. 252T>C human ARSB mutation knock-in. | Biochem Biophys Rep | 2022 | 36032399 | PubTator, text mining | PubMed |
| Genome mining, phylogenetic, and functional analysis of arsenic (As) resistance operons in Bacillus strains, isolated from As-rich hot spring microbial mats. | Microbiol Res | 2022 | 36027845 | PubTator, text mining | PubMed |
| Detection of Structural Variants by NGS: Revealing Missing Alleles in Lysosomal Storage Diseases. | Biomedicines | 2022 | 36009380 | PubTator, text mining | PubMed |
| Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders. | Bioengineering (Basel) | 2022 | 36004917 | PubTator, text mining | PubMed |
| Cellular and molecular characterization of two novel asparagine synthetase gene mutations linked to asparagine synthetase deficiency. | J Biol Chem | 2022 | 35985424 | PubTator, text mining | PubMed |
| Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy. | Oncogenesis | 2022 | 35970822 | PubTator, text mining | PubMed |
| Autophagy related DNA methylation signature predict clinical prognosis and immune microenvironment in low-grade glioma. | Transl Cancer Res | 2022 | 35966301 | PubTator, text mining | PubMed |
| Phenotypic expansion of ARSK-related mucopolysaccharidosis. | Am J Med Genet A | 2022 | 35959767 | PubTator, text mining | PubMed |
| HYAL3 as a potential novel marker of BLCA patient prognosis. | BMC Genom Data | 2022 | 35945500 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression. | Cell Death Dis | 2022 | 35931686 | PubTator, text mining | PubMed |
| Transcriptome variation in human tissues revealed by long-read sequencing. | Nature | 2022 | 35922509 | PubTator, text mining | PubMed |
| Mammalian Sulfatases: Biochemistry, Disease Manifestation, and Therapy. | Int J Mol Sci | 2022 | 35897729 | PubTator, text mining | PubMed |
| Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice. | J Pers Med | 2022 | 35887589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/411/papers?page=13